Remove about responsibility human-rights
article thumbnail

Which immune-humanized platform is right for my application?

Drug Discovery World

Humanization of highly immunodeficient NSG mice with hematopoietic stem cells or peripheral blood mononuclear cells provides a powerful platform for very precise modeling of human immune responses. Join DDW for this exclusive free event, Comparing immune-humanized platforms: Which one is best for my application?

article thumbnail

Webinar: How to choose the right immune-humanized platform

Drug Discovery World

Humanization of highly immunodeficient NSG mice with hematopoietic stem cells or peripheral blood mononuclear cells provides a powerful platform for very precise modeling of human immune responses. Join DDW for this exclusive free event, Comparing immune-humanized platforms: Which one is best for my application?

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Optimizing Your Human Research Protection Program: The Role of Quality Training

Advarra

For research administrators, having a robust human research protection program (HRPP) in place is vital. An HRPP is responsible for protecting participant rights and the welfare of research conducted or reviewed at an organization. Understanding HRPP and its Key Elements Research institutions must take their HRPP seriously.

article thumbnail

The biotech improving immunotherapies with AI

Drug Discovery World

DDW Editor Reece Armstrong speaks to Ron Alfa , CEO & Co-founder at NOETIK, about the company’s mission to utilise artificial intelligence (AI) and spatial biology to develop better immunotherapies for cancer patients. Reece A: What are some of the human limitations to current drug discovery research for immunotherapies?

Genome 52
article thumbnail

Grand Rounds August 4, 2023: AI & ML: Want to Play a Game? (Eric Perakslis, PhD)

Rethinking Clinical Trials

Those NPCs learn from interacting with human intelligence. This concept could be an interesting way to think about consent. What is going to keep AI in the boundaries for health hand research right now? ” The key to quality of AI and utilizing AI in a beneficial way relates to the quality of the data.

article thumbnail

EMA CHMP recommends Moderna’s Covid-19 booster for children

Pharmaceutical Technology

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended granting variation to the marketing authorization (MA) for Moderna ’s Spikevax bivalent Original/Omicron BA.1 1 (mRNA-1273.214) booster for usage in children aged six to 11 years. 5), mRNA-1273.

article thumbnail

Grifols’ Innovation Strategy in the Plasma Medicine Space

XTalks

Plasma medicine is a critical and specialized field within healthcare, centering on the use of human plasma for the development and administration of life-saving treatments. Human plasma, the clear, liquid portion of blood, is composed of water, electrolytes, nutrients and crucial proteins such as antibodies, clotting factors and albumin.

Medicine 111